Operational note: updated commissioning recommendations for medical retinal vascular medicines following the national procurement for ranibizumab biosimilars

Document first published:
Page updated:
Topic:
,
Publication type:

Updated commissioning recommendations for licensed intravitreal anti-VEGF and corticosteroid treatments in England for medical retinal conditions.

Link

Operational note: updated commissioning recommendations for medical retinal vascular medicines following the national procurement for ranibizumab biosimilars

Operational note: updated commissioning recommendations for medical retinal vascular medicines following the national procurement for ranibizumab biosimilars

NHS England is not responsible for content on external websites.

Summary

Version 2, updated 24 July 2023.